Terms: = Leukemia AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
161 results:
1. Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia.
Benegas P; Ziegler B; Dieminger V; Bengió R; Zapata P; Larripa I; Ferri C
Gene; 2024 Feb; 896():148047. PubMed ID: 38042214
[TBL] [Abstract] [Full Text] [Related]
2. RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1.
Azlan A; Khor KZ; Rajasegaran Y; Rosli AA; Said MSM; Yusoff NM; Moses EJ
Med Oncol; 2023 Jun; 40(7):208. PubMed ID: 37341821
[TBL] [Abstract] [Full Text] [Related]
3. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
Lees J; Hay J; Moles MW; Michie AM
Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
[TBL] [Abstract] [Full Text] [Related]
4. Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Jambrovics K; Botó P; Pap A; Sarang Z; Kolostyák Z; Czimmerer Z; Szatmari I; Fésüs L; Uray IP; Balajthy Z
Cell Death Dis; 2023 Mar; 14(3):217. PubMed ID: 36977701
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia.
Xu Z; Pan B; Miao Y; Li Y; Qin S; Liang J; Kong Y; Zhang X; Tang J; Xia Y; Zhu H; Wang L; Li J; Wu J; Xu W
Clin Exp Med; 2023 Oct; 23(6):2651-2662. PubMed ID: 36738306
[TBL] [Abstract] [Full Text] [Related]
6. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
[TBL] [Abstract] [Full Text] [Related]
7. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
[TBL] [Abstract] [Full Text] [Related]
8. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
9. Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance.
Emdal KB; Palacio-Escat N; Wigerup C; Eguchi A; Nilsson H; Bekker-Jensen DB; Rönnstrand L; Kazi JU; Puissant A; Itzykson R; Saez-Rodriguez J; Masson K; Blume-Jensen P; Olsen JV
Cell Rep; 2022 Aug; 40(6):111177. PubMed ID: 35947955
[TBL] [Abstract] [Full Text] [Related]
10. The association between foxo3a rs4946936 gene polymorphism and the levels of foxo3a among chronic granulocytic leukemia patients treated with imatinib mesylate.
Wardhani SO; Susianti H; Rahayu P; Yueniwati YP; Fajar JK
F1000Res; 2021; 10():1003. PubMed ID: 35464180
[No Abstract] [Full Text] [Related]
11. The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation.
Lyu ZS; Tang SQ; Xing T; Zhou Y; Lv M; Fu HX; Wang Y; Xu LP; Zhang XH; Lee HY; Kong Y; Huang XJ
Haematologica; 2022 Oct; 107(10):2365-2380. PubMed ID: 35354250
[TBL] [Abstract] [Full Text] [Related]
12. MAP kinase-dependent autophagy controls phorbol myristate acetate-induced macrophage differentiation of HL-60 leukemia cells.
Mandic M; Misirkic Marjanovic M; Vucicevic L; Jovanovic M; Bosnjak M; Perovic V; Ristic B; Ciric D; Harhaji-Trajkovic L; Trajkovic V
Life Sci; 2022 May; 297():120481. PubMed ID: 35304128
[TBL] [Abstract] [Full Text] [Related]
13. [The Relationship between MicroRNA Expression Profiling in Imatinib-Resistant Cell Line K562/G and Potential Mechanism through foxo3/Bcl-6 Signaling Pathway].
Shen J; Wang H; Wang JS; Wei N; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):107-112. PubMed ID: 35123611
[TBL] [Abstract] [Full Text] [Related]
14. WTIP upregulates foxo3a and induces apoptosis through PUMA in acute myeloid leukemia.
Zhu Y; Tong X; Wang Y; Lu X
Cell Death Dis; 2021 Dec; 13(1):18. PubMed ID: 34930905
[TBL] [Abstract] [Full Text] [Related]
15. Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells.
Bakhshayesh M; Gohari LH; Barati M; Safa M
Biomol Concepts; 2021 Oct; 12(1):144-155. PubMed ID: 34700368
[TBL] [Abstract] [Full Text] [Related]
16. Cell Line-Specific Network Models of ER
Gómez Tejeda Zañudo J; Mao P; Alcon C; Kowalski K; Johnson GN; Xu G; Baselga J; Scaltriti M; Letai A; Montero J; Albert R; Wagle N
Cancer Res; 2021 Sep; 81(17):4603-4617. PubMed ID: 34257082
[TBL] [Abstract] [Full Text] [Related]
17. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by foxo3a activation in myelodysplastic syndromes.
Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
[TBL] [Abstract] [Full Text] [Related]
18. Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs.
Mehrpouri M; Momeny M; Bashash D
J Recept Signal Transduct Res; 2022 Feb; 42(1):100-108. PubMed ID: 33969806
[TBL] [Abstract] [Full Text] [Related]
19. DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways.
Ma L; Chen Z; Li J; Zhang H; Jia Y; Liu J
J Ethnopharmacol; 2021 Oct; 279():113889. PubMed ID: 33524514
[TBL] [Abstract] [Full Text] [Related]
20. Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.
Liu Y; Cai B; Chong Y; Zhang H; Kemp CA; Lu S; Chang CS; Ren M; Cowell JK; Hu T
Cell Death Dis; 2020 Oct; 11(10):884. PubMed ID: 33082322
[TBL] [Abstract] [Full Text] [Related]
[Next]
